Personalized Outreach for Equitable Treatment in Rheumatology (NCT07022756)
Personalized Outreach for Equitable Treatment in Rheumatology: A Randomized Controlled Trial of Patient Outreach and Honoraria in an Inner City Rheumatology Clinic
🩺 Plain-English Summary (8th-Grade Level)
The primary goal of this study is to determine whether providing patient honoraria and/or outreach services can improve the attendance rate of appointments at an inner city rheumatology clinic in Vancouver, British Columbia. The main question it aims to answer are: * Does providing a financial honorarium ($20 for each follow-up appointment with completed bloodwork) improve attendance rate at an inner city rheumatology clinic? * Does providing a personalized outreach service for rheumatic diseases improve attendance rate at an inner city rheumatology clinic? The researchers will compare providing patient honoraria to providing both honoraria and outreach services, and compare each of these to the regular appointment schedule without honoraria or outreach. Participants will: * Undergo randomization to receive honoraria or honoraria and outreach services together * Complete surveys about their health and understanding of their rheumatic disease at baseline, 3-month, and 6-month intervals * Visit the clinic every month for check-ups and monitoring bloodwork if they are started on immunosuppressants for their condition
Who can join: Review the eligibility criteria below.
Location: Pender Community Health Centre — Vancouver, British Columbia
Age range: 18 Years
🧪 Interventions in This Study
- Honoraria (BEHAVIORAL)
- Outreach (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Pender Community Health Centre — Vancouver, British Columbia
📞 Contact the Study Coordinator
Phone: (778) 807-3323
Email: alec.yu@vch.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Rheumatic Diseases
- Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases — Chicago, Illinois
- The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd) — Northport, Alabama
- Rheumatology Patient Registry and Biorepository — New Haven, Connecticut
- The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions — Montreal, Quebec
- Studies of the Natural History of Rheumatic Diseases — Bethesda, Maryland
Explore by condition: All Rheumatic Diseases clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.